immune response to tirzepatide (LY3298176) is a Dual GIP and GLP-1 Receptor Agonist for Type 2 Diabetes Research The Novel Dual GIP and

After recent moves by weight loss companies WW and Noom to dive into telehealth prescribing, drugmaker Eli Lilly is starting a service that will connect people needing medications for obesity, diabetes and migraine to clinicians via virtual visits and deliver medications directly to their homes.

Restore volume after GLP-1 weight loss with Sculptra at Enfuse Medical Spas in Chicagogentle, long-lasting collagen stimulation for facial rejuvenation.

Local Park City resident and founder of the Kresser Institute, Chris Kresser joins the show

Ozempic is a once weekly injection of semaglutide developed for adults living with type 2 diabetes

Explore alternatives to GLP-1 weight loss drugs if insurance wont cover them, including appeals, discounts, other medications, surgery, and lifestyle changes.

While most of the recent fanfare has been related to their ro...